Evidence map›Paper›PMID 31279825›Full record

ArticleNeuroscience2019

GPR55-mediated effects on brain microvascular endothelial cells and the blood-brain barrier.

Luciana M Leo, Boluwatife Familusi, Michelle Hoang, Raymond Smith, Kristen Lindenau, Kevin T Sporici, Eugen Brailoiu, Mary E Abood, G Cristina Brailoiu

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Modulation of the Blood-Brain Barrier by Sigma-1R Activation.International journal of molecular sciences · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Luciana M LeoCenter for Substance Abuse Research, Lewis Katz School of Medicine, Philadelphia, PA 19140, USA.
Boluwatife FamilusiDepartment of Pharmaceutical Sciences, Jefferson College of Pharmacy, Philadelphia, PA 19107, USA.
Michelle HoangDepartment of Pharmaceutical Sciences, Jefferson College of Pharmacy, Philadelphia, PA 19107, USA.
Raymond SmithDepartment of Pharmaceutical Sciences, Jefferson College of Pharmacy, Philadelphia, PA 19107, USA.
Kristen LindenauDepartment of Pharmaceutical Sciences, Jefferson College of Pharmacy, Philadelphia, PA 19107, USA.
Kevin T SporiciDepartment of Pharmaceutical Sciences, Jefferson College of Pharmacy, Philadelphia, PA 19107, USA.
Eugen BrailoiuCenter for Substance Abuse Research, Lewis Katz School of Medicine, Philadelphia, PA 19140, USA.
Mary E AboodCenter for Substance Abuse Research, Lewis Katz School of Medicine, Philadelphia, PA 19140, USA.
G Cristina BrailoiuDepartment of Pharmaceutical Sciences, Jefferson College of Pharmacy, Philadelphia, PA 19107, USA. Electronic address: Gabriela.Brailoiu@jefferson.edu.
Jefferson College · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Munir Gunes Kutlu · 2000 to 2026
$34.6M
TRAINING PROGRAM: DRUGS OF ABUSE RELATED NEUROPEPTIDEST32DA007237 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ELLEN M UNTERWALD · 1988 to 2026
$10.6M
Functional Role for GPR55 in the periaqueductal grayR01DA035926 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI ABOOD, MARY E, BENAMAR, KHALID · 2014 to 2018
$1.6M
Modulation of the Blood-Brain Barrier by Novel Cannabinoid ReceptorsR03NS099957 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI BRAILOIU, GABRIELA CRISTINA · 2018 to 2019
$156k
NIDA NIH HHS P30 DA013429NIDA NIH HHS R01 DA035926NIDA NIH HHS T32 DA007237NINDS NIH HHS R03 NS099957
6 · The paper itself

Abstract

GPR55, an atypical cannabinoid receptor activated by lysophosphatidylinositol (LPI) has been involved in various physiological and pathological processes. We examined the effect of GPR55 activation on rat brain microvascular endothelial cells (RBMVEC), an essential component of the blood-brain barrier (BBB). GPR55 was detected in RBMVEC by western blot and immunocytochemistry. Treatment of RBMVEC with LPI increased cytosolic Ca

Indexed as

AnimalsBlood-Brain BarrierCalciumCalcium SignalingCell LineDose-Response Relationship, DrugEndothelial CellsLysophospholipidsMaleMembrane PotentialsMicrovesselsRatsRats, Sprague-DawleyReceptors, CannabinoidReceptors, G-Protein-CoupledCalciumGPR55 protein, ratlysophosphatidylinositolLysophospholipidsReceptors, CannabinoidReceptors, G-Protein-Coupledblood–brain barriercalcium signalingelectrical resistanceLPI

Identifiers

PMID31279825
PMCPMC6684354
OpenAlexW2953954107

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.